Essex Bio-Technology Limited (1061.HK)
HKD 2.76
(0.37%)
HKD 2.76
(0.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 294.02 Million HKD | -39.96% |
| 2022 | 489.73 Million HKD | -13.35% |
| 2021 | 565.18 Million HKD | 0.43% |
| 2020 | 562.77 Million HKD | 52.39% |
| 2019 | 369.29 Million HKD | 95.02% |
| 2018 | 189.36 Million HKD | 19.87% |
| 2017 | 157.97 Million HKD | -1.4% |
| 2016 | 160.21 Million HKD | 214.15% |
| 2015 | 51 Million HKD | 0.89% |
| 2014 | 50.54 Million HKD | -0.43% |
| 2013 | 50.76 Million HKD | -31.23% |
| 2012 | 73.81 Million HKD | 0.0% |
| 2011 | - HKD | 0.0% |
| 2010 | - HKD | 0.0% |
| 2009 | - HKD | -100.0% |
| 2008 | 34.63 Million HKD | 19.89% |
| 2007 | 28.89 Million HKD | 480.11% |
| 2006 | 4.98 Million HKD | 0.0% |
| 2005 | - HKD | -100.0% |
| 2004 | 72.53 Thousand HKD | -57.14% |
| 2003 | 169.24 Thousand HKD | -98.29% |
| 2002 | 9.87 Million HKD | 0.0% |
| 2001 | - HKD | -100.0% |
| 2000 | 16.6 Million HKD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 306.53 Million HKD | 0.0% |
| 2023 FY | 294.02 Million HKD | -39.96% |
| 2023 Q2 | 446.08 Million HKD | 0.0% |
| 2023 Q4 | 294.02 Million HKD | 0.0% |
| 2022 Q2 | 512.51 Million HKD | 0.0% |
| 2022 FY | 489.73 Million HKD | -13.35% |
| 2022 Q4 | 489.73 Million HKD | 0.0% |
| 2021 Q2 | 562.1 Million HKD | 0.0% |
| 2021 Q4 | 565.18 Million HKD | 0.0% |
| 2021 FY | 565.18 Million HKD | 0.43% |
| 2020 Q2 | 361.36 Million HKD | 0.0% |
| 2020 FY | 562.77 Million HKD | 52.39% |
| 2020 Q4 | 562.77 Million HKD | 0.0% |
| 2019 Q4 | 369.29 Million HKD | 0.0% |
| 2019 Q2 | 242.83 Million HKD | 0.0% |
| 2019 FY | 369.29 Million HKD | 95.02% |
| 2018 Q2 | 186.6 Million HKD | 0.0% |
| 2018 Q4 | 189.36 Million HKD | 0.0% |
| 2018 FY | 189.36 Million HKD | 19.87% |
| 2017 FY | 157.97 Million HKD | -1.4% |
| 2017 Q2 | 165.03 Million HKD | 0.0% |
| 2017 Q4 | 157.97 Million HKD | 0.0% |
| 2016 Q4 | 160.21 Million HKD | 0.0% |
| 2016 Q2 | 158.85 Million HKD | 0.0% |
| 2016 FY | 160.21 Million HKD | 214.15% |
| 2015 Q4 | 51 Million HKD | 0.0% |
| 2015 Q2 | 31.62 Million HKD | 0.0% |
| 2015 FY | 51 Million HKD | 0.89% |
| 2014 Q2 | 56.66 Million HKD | 0.0% |
| 2014 Q4 | 50.54 Million HKD | 0.0% |
| 2014 FY | 50.54 Million HKD | -0.43% |
| 2013 Q4 | 50.76 Million HKD | 0.0% |
| 2013 FY | 50.76 Million HKD | -31.23% |
| 2013 Q2 | 69.11 Million HKD | 0.0% |
| 2012 Q4 | 73.81 Million HKD | 0.0% |
| 2012 FY | 73.81 Million HKD | 0.0% |
| 2012 Q2 | 36.88 Million HKD | 0.0% |
| 2011 FY | - HKD | 0.0% |
| 2011 Q4 | - HKD | 0.0% |
| 2011 Q2 | - HKD | 0.0% |
| 2010 Q2 | - HKD | 0.0% |
| 2010 FY | - HKD | 0.0% |
| 2009 FY | - HKD | -100.0% |
| 2008 FY | 34.63 Million HKD | 19.89% |
| 2007 FY | 28.89 Million HKD | 480.11% |
| 2006 FY | 4.98 Million HKD | 0.0% |
| 2005 FY | - HKD | -100.0% |
| 2004 FY | 72.53 Thousand HKD | -57.14% |
| 2003 FY | 169.24 Thousand HKD | -98.29% |
| 2002 FY | 9.87 Million HKD | 0.0% |
| 2001 FY | - HKD | -100.0% |
| 2000 FY | 16.6 Million HKD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 6.8 Million HKD | -4217.508% |
| Grand Pharmaceutical Group Limited | 3.4 Billion HKD | 91.363% |
| Extrawell Pharmaceutical Holdings Limited | 120.41 Million HKD | -144.184% |
| Wai Yuen Tong Medicine Holdings Limited | 460.94 Million HKD | 36.214% |
| Qianhai Health Holdings Limited | 487 Thousand HKD | -60274.173% |
| Lee's Pharmaceutical Holdings Limited | 204.14 Million HKD | -44.03% |
| Tongfang Kontafarma Holdings Limited | 333.82 Million HKD | 11.923% |
| PuraPharm Corporation Limited | 424.77 Million HKD | 30.781% |
| SSY Group Limited | 3.37 Billion HKD | 91.286% |
| JBM (Healthcare) Limited | 133.4 Million HKD | -120.395% |
| Jacobson Pharma Corporation Limited | 749.37 Million HKD | 60.765% |
| China Resources Pharmaceutical Group Limited | 85.84 Billion HKD | 99.658% |